Skip to content
S10480Senate2025-2026 Session

Cover Heart Calcium Tests

Official title

“Provides for mandatory health insurance coverage for coronary artery calcium diagnostic testing”

Sponsor Jessica Scarcella-SpantonSD-23Affects Finance
Status
In Senate Committee
Insurance
Impact
7/10
Significant
Passage
1%

Bill progress

Step 2 of 7

In committee · Insurance

What's happening

This bill requires all health insurance policies in New York to cover coronary artery calcium diagnostic testing without patient cost sharing.

Why it matters

  1. Makes coronary artery calcium testing more accessible statewide. by requiring all major health insurance plans in New York—including employer-sponsored, individual, and group policies—to cover this heart disease screening if recommended by a healthcare provider, potentially benefiting millions of New Yorkers at risk for cardiovascular disease.

  2. Removes out-of-pocket barriers for most patients. by prohibiting cost sharing (like copays or coinsurance) for this testing, which can help lower-income and underinsured residents get preventive care—though those with high-deductible health plans linked to HSAs may still need to meet their deductible first.

  3. Limits unnecessary or inappropriate use. by allowing insurers to require preauthorization and to review medical necessity, ensuring coverage aligns with evidence-based guidelines and that testing is provided to those who are most likely to benefit, rather than on demand.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

  • Patients at Risk of Cardiovascular Disease

    Individuals who may benefit from coronary artery calcium diagnostic testing for early detection and prevention of heart disease, especially those with risk factors or family history.

  • Health Care Providers

    Physicians, cardiologists, and other clinicians who recommend and order diagnostic tests, and who seek insurance coverage to ensure their patients receive evidence-based care without cost barriers.

  • Health Insurance Companies

    Insurers and health plans that will be required to cover coronary artery calcium diagnostic testing with no patient cost-sharing (except for some high-deductible health plans), impacting plan design and potential costs.

  • Medical Professional Societies and Advocacy Groups

    Organizations that develop clinical guidelines and advocate for access to preventive cardiovascular care, whose guidelines are referenced for coverage decisions under this legislation.

Headline styles

Cover Heart Calcium Tests

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Jessica Scarcella-Spanton

Senator · Senate District 23

Chair, Veterans, Homeland Security And Military Affairs

No co-sponsors yet.

History

  1. Referred to insurance

Full text

3 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

10480

IN SENATE

May 15, 2026

Introduced by Sen. SCARCELLA-SPANTON -- read twice and ordered printed, and when printed to be committed to the Committee on Insurance

AN ACT to amend the insurance law, in relation to mandatory health insurance coverage for coronary artery calcium diagnostic testing

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Subsection (i) of section 3216 of the insurance law is amended by adding a new paragraph 42 to read as follows:

(42) (A) Every policy which provides medical, major medical, or similar comprehensive-type coverage shall provide coverage for coronary artery calcium diagnostic testing upon the recommendation of a health care provider acting within such provider's scope of practice pursuant to title eight of the education law, and as recommended by nationally recognized clinical practice guidelines for the prevention of cardiovascular disease.

(B) Notwithstanding any other provision of law, any policy that provides coverage required by this paragraph shall not impose patient cost sharing for coronary artery calcium diagnostic testing.

(C) For the purposes of this paragraph, the term "nationally recognized clinical practice guidelines" shall mean evidence-based, peer reviewed clinical practice guidelines informed by a systematic review of evidence and an assessment of the benefits, and risks of alternative care options intended to optimize patient care developed by independent organizations or medical professional societies utilizing a transparent methodology and reporting structure and with a conflict of interest policy.

(D) Nothing in this paragraph shall be construed to prevent medical management or utilization review of the services, including preauthorization, to ensure that such services are consistent with nationally recognized clinical practice guidelines for the prevention of cardiovascular disease.

(E) If the policy is a high deductible health plan as defined in section 223(c)(2) of the Internal Revenue Code of 1986, such coverage

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD15931-01-6

may be subject to the plan's annual deductible if application of this requirement would result in ineligibility for a health savings account.

§ 2. Subsection (l) of section 3221 of the insurance law is amended by adding a new paragraph 24 to read as follows:

(24) (A) Every policy which provides medical, major medical, or similar comprehensive-type coverage shall provide coverage for coronary artery calcium diagnostic testing upon the recommendation of a health care provider acting within such provider's scope of practice pursuant to title eight of the education law, and as recommended by nationally recognized clinical practice guidelines for the prevention of cardiovascular disease.

(B) Notwithstanding any other provision of law, any policy that provides coverage required by this paragraph shall not impose patient cost sharing for coronary artery calcium diagnostic testing.

(C) For the purposes of this paragraph, the term "nationally recognized clinical practice guidelines" shall mean evidence-based, peer reviewed clinical practice guidelines informed by a systematic review of evidence and an assessment of the benefits, and risks of alternative care options intended to optimize patient care developed by independent organizations or medical professional societies utilizing a transparent methodology and reporting structure and with a conflict of interest policy.

(D) Nothing in this paragraph shall be construed to prevent medical management or utilization review of the services, including preauthorization, to ensure that such services are consistent with nationally recognized clinical practice guidelines for the prevention of cardiovascular disease.

(E) If the policy is a high deductible health plan as defined in section 223(c)(2) of the Internal Revenue Code of 1986, such coverage may be subject to the plan's annual deductible if application of this requirement would result in ineligibility for a health savings account.

§ 3. Section 4303 of the insurance law is amended by adding a new subsection (yy) to read as follows:

(yy) (1) Every contract which provides medical, major medical, or similar comprehensive-type coverage shall provide coverage for coronary artery calcium diagnostic testing upon the recommendation of a health care provider acting within such provider's scope of practice pursuant to title eight of the education law, and as recommended by nationally recognized clinical practice guidelines for the prevention of cardiovascular disease.

(2) Notwithstanding any other provision of law, any contract that provides coverage required by this subsection shall not impose patient cost sharing for coronary artery calcium diagnostic testing.

(3) For the purposes of this subsection, the term "nationally recognized clinical practice guidelines" shall mean evidence-based, peer reviewed clinical practice guidelines informed by a systematic review of evidence and an assessment of the benefits, and risks of alternative care options intended to optimize patient care developed by independent organizations or medical professional societies utilizing a transparent methodology and reporting structure and with a conflict of interest policy.

(4) Nothing in this subsection shall be construed to prevent medical management or utilization review of the services, including preauthorization, to ensure that such services are consistent with nationally recognized clinical practice guidelines for the prevention of cardiovascular disease.

(5) If the contract is a high deductible health plan as defined in section 223(c)(2) of the Internal Revenue Code of 1986, such coverage may be subject to the plan's annual deductible if application of this requirement would result in ineligibility for a health savings account.

§ 4. This act shall take effect January 1, 2027 and shall apply to all policies and contracts issued, renewed, modified, altered or amended on or after such date.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the insurance law, in relation to mandatory health insurance coverage for coronary artery calcium diagnostic testing

Purpose or general idea of bill

The purpose of this legislation is to provide mandatory health insurance coverage for coronary artery calcium diagnostic testing.

Summary of provisions

Section 1. Section 3216 of the insurance law is amended by adding an new paragraph to read, every policy which provides medical, major medical, or similar comprehensive-type coverage shall provide coverage for coro- nary artery calcium diagnostic testing upon the recommendation of a health care provider acting within such provider's scope of practice pursuant to title eight of the education law, and as recommended by nationally recognized clinical practice guidelines for the prevention of cardiovascular disease.

Notwithstanding any other provision of law, any policy that provides coverage required by this paragraph shall not impose patient cost shar- ing for coronary artery calcium diagnostic testing.

For the purposes of this paragraph, the term "nationally recognized clinical practice guidelines shall mean evidence-based, peer reviews clinical practice guidelines informed by a systematic review of evidence and an assessment of the benefits, and risks of alternative care options intended to optimize patient care developed by independent organizations or medical professional societies utilizing a transparent methodology and reporting structure and with conflict of interest policy.

Nothing in this paragraph shall be construed to prevent medical manage- ment or utilization review of the services, including preauthorization, to ensure that such services are consistent with nationally recognized clinical practice guidelines for the prevention of cardiovascular disease.

If the policy is a high-deductible health plan as defined in section 223 0 (2) of the Internal Revenue Code of 1986, such coverage may be subject to the plan's annual deductible if application of this requirement would result in in ineligibility for a health savings account.

Section 2. Amends section 3221 of the insurance law by adding a new paragraph 24. Section 3. Amends the insurance law section 4303.

Section 4. This act shall take effect January 1, 2027, and shall apply to all policies and contracts issues, renewed, modified, altered, or amended on or after such date.

Justification

This important legislation requiring all public and private health insurance plans in New York State to cover Coronary Artery Calcium (CAC) testing as a medically necessary preventive diagnostic service. Cardiovascular disease remains the leading cause of death in New York State, accounting for more than 50,000 deaths statewide in 2021. CAC testing is a safe, non-invasive screening tool that helps detect coro- nary artery disease before symptoms arise and allows physicians to iden- tify individuals at elevated risk for heart attacks and other serious cardiac events.

Despite its proven effectiveness and support from organizations such as the American Heart Association and the American College of Cardiology, CAC testing is frequently not covered by insurance, forcing many New Yorkers to pay significant out-of-pocket costs. These financial barri- ers disproportionately impact low and moderate-income individuals and limit access to early detection and preventive care.

This legislation will address four key areas of coronary health care by expanding access to preventive cardiac care, reducing long-term health- care costs through early intervention, address healthcare inequities, and prevent avoidable cardiac emergencies and deaths.

Prior legislative history

This is new legislation.

Fiscal implications for state and local governments

Yet to be Determined

Effective date

This act shall take effect January 1, 2027, and shall apply to all poli- cies and contracts issues, renewed, modified, altered, or amended on or after such date.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.